Gelsolin siRNA (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Gelsolin siRNA (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Gelsolin siRNA (h)

Description

Gelsolin siRNA (h)

Product Specs
ItemGelsolin siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-37330
Gene Namegelsolin
Quantity10 µM
Specieshuman
NCBI Full Gene Namegelsolin
NCBI Gene AliasesADF, AGEL
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) 2D-DIGE-MS Proteomics Approaches for Identification of Gelsolin and Peroxiredoxin 4 with Lymph Node Metastasis in Colorectal CancerCancersJune 29, 2022Huang CY, Lee KC, Tung SY, Huang WS, Teng CC, Lee KF, Hsieh MC, Kuo HC.

(2) Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic MachineryAnticancer researchAugust 1, 2021Oelrich F, Junker H, Stope MB, Erb HHH, Walther R, Venz S, Zimmermann U.

(3) Synthetic alkyl-ether-lipid promotes TRPV2 channel trafficking trough PI3K/Akt-girdin axis in cancer cells and increases mammary tumour volumeCell calciumJune 12, 2021Guéguinou M, Felix R, Marionneau-Lambot S, Oullier T, Penna A, Kouba S, Gambade A, Fourbon Y, Ternant D, Arnoult C, et al.

(4) Actin cables and comet tails organize mitochondrial networks in mitosisNatureMarch 1, 2021Moore AS, Coscia SM, Simpson CL, Ortega FE, Wait EC, Heddleston JM, Nirschl JJ, Obara CJ, Guedes-Dias P, Boecker CA, et al.

(5) Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5pCancer scienceJuly 1, 2020Zhang J, Furuta T, Sabit H, Tamai S, Jiapaer S, Dong Y, Kinoshita M, Uchida Y, Ohtsuki S, Terasaki T, et al.

(6) Gelsolin Promotes Radioresistance in Non-Small Cell Lung Cancer Cells Through Activation of Phosphoinositide 3-Kinase/Akt SignalingTechnology in cancer research & treatmentAugust 1, 2017Zhao RS, Wang W, Li JP, Liu CM, He L.

Be the First to Write a Review!